U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
  • Quoted phrase not found.
  • See the search details.
Trifluridine-Tipiracil (Lonsurf): CADTH Reimbursement Recommendation: Indication: In combination with bevacizumab, for the treatment of adult patients with metastatic colorectal cancer who have previously been treated with, or are not candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-VEGF biological agents, and, if RAS wild-type, anti-EGFR agents [Internet].

Trifluridine-Tipiracil (Lonsurf): CADTH Reimbursement Recommendation: Indication: In combination with bevacizumab, for the treatment of adult patients with metastatic colorectal cancer who have previously been treated with, or are not candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-VEGF biological agents, and, if RAS wild-type, anti-EGFR agents [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Mar.

Table of contents


Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...